Quick Answer
TEVA PHARMACEUTICAL INDUSTRIES LTD reported Earnings Per Share Diluted of $1.21 per share for the year ending 2025.
- TEVA PHARMACEUTICAL INDUSTRIES LTD showed an increase of +183.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from TEVA PHARMACEUTICAL INDUSTRIES LTD's annual report (Form 10-K), filed with the SEC on February 3, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), TEVA PHARMACEUTICAL INDUSTRIES LTD's Earnings Per Share Diluted has grown by 61.3%.
- Historical annual values: Fiscal year 2025: $1.21 per share | Fiscal year 2024: $1.45 (loss) per share | Fiscal year 2023: $0.50 (loss) per share | Fiscal year 2022: $2.20 (loss) per share | Fiscal year 2021: $0.38 per share | Fiscal year 2020: $3.64 (loss) per share | Fiscal year 2019: $0.91 (loss) per share | Fiscal year 2018: $2.35 (loss) per share | Fiscal year 2017: $16.26 (loss) per share | Fiscal year 2016: $0.07 per share | Fiscal year 2015: $1.82 per share | Fiscal year 2014: $3.56 per share | Fiscal year 2013: $1.49 per share | Fiscal year 2012: $2.25 per share | Fiscal year 2011: $3.09 per share | Fiscal year 2010: $3.67 per share | Fiscal year 2009: $2.23 per share | Fiscal year 2008: $0.75 per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: